PAIN
Volume 142, Issue 3 , Pages 218-224 , April 2009

The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS

  • M. de Mos

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Dr. Molewaterplein 50, Room 2157, 3015 GE, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Erasmus University Medical Center, Pharmaco-epidemiology Unit, Department of Medical Informatics, Dr. Molewaterplein 50, Room 2157, 3015 GE Rotterdam, The Netherlands. Tel.: +31 10 7044128; fax: +31 10 7044722.
    • ,
  • F.J.P.M. Huygen

      Affiliations

    • Erasmus University Medical Center, Department of Pain Treatment, ‘s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    • ,
  • B.H.Ch. Stricker

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Dr. Molewaterplein 50, Room 2157, 3015 GE, Rotterdam, The Netherlands
    • ,
  • J.P. Dieleman

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Dr. Molewaterplein 50, Room 2157, 3015 GE, Rotterdam, The Netherlands
    • ,
  • M.C.J.M. Sturkenboom

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Dr. Molewaterplein 50, Room 2157, 3015 GE, Rotterdam, The Netherlands

Received 15 August 2008 ,Revised 2 December 2008 ,Accepted 23 December 2008.

References 

  1. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116:213–219
  2. Anonymous. ATC and DDD values. Geneva: WHO; 1996;
  3. Birklein F, Riedl B, Sieweke N, Weber M, Neundorfer B. Neurological findings in complex regional pain syndromes – analysis of 145 cases. Acta Neurol Scand. 2000;101:262–269
  4. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001;57:2179–2184
  5. Blair SJ, Chinthagada M, Hoppenstehdt D, Kijowski R, Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belg. 1998;64:448–451
  6. Brain SD, Tippins JR, Morris HR, MacIntyre I, Williams TJ. Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol. 1986;87:533–536
  7. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985;313:54–56
  8. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol. 2001;429:161–176
  9. de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129:12–20
  10. de Mos M, Huygen FJPM, Dieleman JP, Koopman JSHA, Stricker BHC, Sturkenboom MCJM. Medical history and the onset of complex regional pain syndrome (CRPS). Pain. 2008;139:458–466
  11. Dendorfer A, Wolfrum S, Wellhoner P, Korsman K, Dominiak P. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart. Br J Pharmacol. 1997;122:1179–1187
  12. Gradl G, Finke B, Schattner S, Gierer P, Mittlmeier T, Vollmar B. Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain. Neuroscience. 2007;148:757–765
  13. Harden RN, Bruehl S. Diagnostic criteria: the statistical derivation of the four criterion factors. In:  Wilson PR,  Stanton-Hicks M,  Harden RN editor. CRPS: current diagnosis and therapy. Seattle: IASP Press; 2005;p. 45–58
  14. Harden RN, Rudin NJ, Bruehl S, Kee W, Parikh DK, Kooch J, et al. Increased systemic catecholamines in complex regional pain syndrome and relationship to psychological factors: a pilot study. Anesth Analg. 2004;99:1478–1485[table of contents]
  15. Heijnen CJ, Rouppe van der Voort C, Wulffraat N, van der Net J, Kuis W, Kavelaars A. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol. 1996;71:223–226
  16. Huhne K, Leis S, Schmelz M, Rautenstrauss B, Birklein F. A polymorphic locus in the intron 16 of the human angiotensin-converting enzyme (ACE) gene is not correlated with complex regional pain syndrome I (CRPS I). Eur J Pain. 2004;8:221–225
  17. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47–51
  18. Kimura T, Komatsu T, Hosada R, Nishiwaki K, Shimada Y. Angiotensin-converting enzyme gene polymorphism in patients with neuropathic pain. In: Proceedings of the ninth World Congress in pain. Seattle, WA: IASP Press; 2000. p. 471–6.
  19. Kramer HH, Schmidt K, Leis S, Schmelz M, Sommer C, Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol. 2005;195:179–184
  20. Kramer HH, Schmidt K, Leis S, Schmelz M, Sommer C, Birklein F. Angiotensin converting enzyme has an inhibitory role in CGRP metabolism in human skin. Peptides. 2006;27:917–920
  21. Leis S, Weber M, Isselmann A, Schmelz M, Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol. 2003;183:197–204
  22. Leis S, Weber M, Schmelz M, Birklein F. Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome. Neurosci Lett. 2004;359:163–166
  23. O’Connor TM, O’Connell J, O’Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201:167–180
  24. Schrijvers AJP. Health and Healthcare in the Netherlands. A critical self-assessment of Dutch experts in medical and health sciences. Utrecht: De Tijdstroom; 1997;
  25. Skidgel RA, Erdos EG. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides. 2004;25:521–525
  26. Snijdelaar DG, Dirksen R, Slappendel R, Crul BJ. Substance P. Eur J Pain. 2000;4:121–135
  27. Stanton-Hicks M, Janig W, Hassenbusch S, Haddox JD, Boas R, Wilson P. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127–133
  28. Uceyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain. 2007;132:195–205
  29. van der Lei J, Duisterhout JS, Westerhof HP, van der Does E, Cromme PV, Boon WM, et al. The introduction of computer-based patient records in the Netherlands. Ann Intern Med. 1993;119:1036–1041
  30. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012–1016
  31. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med. 1999;38:339–344
  32. Wang H, Ehnert C, Brenner GJ, Woolf CJ. Bradykinin and peripheral sensitization. Biol Chem. 2006;387:11–14
  33. Wasner G, Heckmann K, Maier C, Baron R. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol. 1999;56:613–620
  34. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82:981–1011
  35. Weber M, Birklein F, Neundorfer B, Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain. 2001;91:251–257
  36. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 1994;62:327–331

PII: S0304-3959(08)00768-9

doi: 10.1016/j.pain.2008.12.032

PAIN
Volume 142, Issue 3 , Pages 218-224 , April 2009

Article Tools

* Image Usage & Resolution